GENINCODE PLC — Investor Relations & Filings
GENINCODE PLC specializes in the genetic risk assessment and prediction of cardiovascular disease (CVD). The company develops and commercializes clinical genetic tests that combine genomic data with clinical algorithms and artificial intelligence (AI). These advanced risk assessment tools provide physicians with a predictive analysis of a patient's health, enabling personalized prevention and treatment strategies for CVD. The company's technology is founded on over 15 years of research and development in cardiovascular genomics, aiming to improve patient outcomes by identifying at-risk individuals before the onset of disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Holding(s) in Company | 2026-05-08 | English | |
| Grant of Share Options & PDMR Dealings | 2026-05-07 | English | |
| Holding(s) in Company | 2026-02-26 | English | |
| Holding(s) in Company | 2026-02-24 | English | |
| Holding(s) in Company | 2026-02-12 | English | |
| Holding(s) in Company | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 44302284 | Holding(s) in Company | 2026-05-08 | English | ||
| 42453279 | Grant of Share Options & PDMR Dealings | 2026-05-07 | English | ||
| 32843679 | Holding(s) in Company | 2026-02-26 | English | ||
| 34563216 | Holding(s) in Company | 2026-02-24 | English | ||
| 19467055 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466908 | Holding(s) in Company | 2026-02-12 | English | ||
| 19466858 | Holding(s) in Company | 2026-02-12 | English | ||
| 18247395 | Result of GM, Director Shareholdings and TVR | 2026-02-09 | English | ||
| 14783432 | Additional Subscription | 2026-02-06 | English | ||
| 13343227 | Result of Retail Offer | 2026-01-26 | English | ||
| 13199807 | Result of Placing and Subscription | 2026-01-22 | English | ||
| 13159849 | Retail Offer | 2026-01-21 | English | ||
| 13159846 | Placing and Subscription | 2026-01-21 | English | ||
|
2025
2 filings
| |||||
| 10225432 | Collaboration with Sohin Genetics | 2025-12-17 | English | ||
| 9627671 | Holding(s) in Company | 2025-12-08 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for GENINCODE PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
NANOVIRICIDES, INC.
Clinical-stage biopharma developing broad-spectrum, nanomed…
|
NNVC | US | Professional, scientific and te… |
|
Natcore Technology Inc.
R&D entity using nanotechnology to improve solar cell effic…
|
NTCXF | CA | Professional, scientific and te… |
|
Nautilus Biotechnology, Inc.
Develops a proteome analysis platform to quantify proteins …
|
NAUT | US | Professional, scientific and te… |
|
NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno…
|
950220 | US | Professional, scientific and te… |
|
Neovacs
Biotech firm developing immunotherapies and investing in Bi…
|
ALNEV | FR | Professional, scientific and te… |
|
NervGen Pharma Corp.
Clinical-stage biotech developing treatments to promote ner…
|
NGEN | CA | Professional, scientific and te… |
|
NEUREN PHARMACEUTICALS LIMITED
Develops innovative therapies for rare neurodevelopmental d…
|
NEU | NZ | Professional, scientific and te… |
|
NEURIZON THERAPEUTICS LIMITED
Clinical-stage developer of mTOR modulators for ALS and neu…
|
NUZ | AU | Professional, scientific and te… |
|
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Develops peptide-based therapeutics for neurodegenerative a…
|
NSB | AU | Professional, scientific and te… |
|
NEUROTECH INTERNATIONAL LIMITED
Clinical-stage biopharmaceutical company developing pediatr…
|
NTI | AU | Professional, scientific and te… |
GENINCODE PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7669/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7669 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7669 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7669 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7669}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENINCODE PLC (id: 7669)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.